To: gingersreisse who wrote (1861 ) 2/5/2000 6:32:00 PM From: BDR Respond to of 10713
<<The 10Q also mentions the firm's equity interests in MVIS, which is seeking CREE's sale of MVIS shares. I'm not familiar with MVIS. Perhaps some of the secondary offering proceeds will buy out MVIS shareholders? >> I may have missed another reference to MVIS in the 10-Q but the only one I could see was the following, which I do not think means that MVIS is seeking CREE's sale of MVIS shares: "As of December 26, 1999, the Company's short-term investments consisted of common stock holdings of Microvision, Inc. ("MVIS"). The Company purchased 268,600 common shares in a private equity transaction in May 1999 at a price of $16.75 per share. In August 1999, MVIS filed a registration statement for the Company's sale of these shares; however, Cree agreed not to sell the shares until at least January 6, 2000. As of December 26, 1999, the Company was restricted from trading these shares and since management views this transaction as an investment, the shares are accounted for as "available for sale" securities under SFAS 115. Therefore unrealized gains or losses are excluded from earnings and are recorded directly in retained earnings." MVIS is developing a virtual retinal display (VRD) utilizing low power lasers to paint high resolution images on the retina. No product yet, but much interest in military, aviation, medical areas (partners are Zeiss, Boeing, and a neuro institute). They presently have beta units producing monochrome images. Commercial development will need full spectrum color, hence the interest in blue lasers. Best way to find out about the company is to go to their website:mvis.com or this site maintained by interested investors:mvispages.com Disclosure: while I have held MVIS in the past I have decided to deploy capital elsewhere (e.g. CREE) until they give evidence that they are closer to a commercial product.